Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
2. The Role of Matrix Metalloproteinase in Inflammation with a Focus on Infectious Diseases
- Lee H.S. , et al.
3. Chronic liver disease in homeless individuals and performance of non-invasive liver fibrosis and injury markers: VALID study
- Hashim A. , et al.
4. Human Exosomes Accelerate Cutaneous Wound Healing by Promoting Collagen Synthesis in a Diabetic Mouse Model
- Zhao B. , et al.
5. Subacute Elevation of Plasma Level of Caspase-Cleaved Cytokeratin-18 is Associated with Hemorrhagic Transformation and Functional Outcome in Ischemic Stroke
- Molnar T. , et al.
6. Nesfatin-1 and caspase-cleaved cytokeratin-18: Promising biomarkers for Alzheimer's disease?
- Alpua M. , et al.
7. Association between serum levels of caspase-cleaved cytokeratin-18 and early mortality in patients with severe spontaneous intracerebral hemorrhage
- Lorente L. , et al.
8. Association between serum cytokeratin-18 neoepitope M30 (CK-18 M30) levels and chronic hepatitis B: A meta-analysis
- Li C. , et al.
9. High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality
- Lorente L. , et al.
10. SHFI: A novel noninvasive predictive model for significant fibrosis in patients with chronic hepatitis B
- Arslan F.D. , et al.
11. Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients
- Lorente L. , et al.
12. Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B
- Li J. , et al.
13. Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B
- Wei X. , et al.
14. Cytokeratin-18 in diagnosis of HCC in patients with liver cirrhosis
- Ismail S.A. , et al.
15. Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease
- Świderska M. , et al.
16. The role of M30 in predicting the severity of liver fibrosis and inflammation in chronic hepatitis B patients
- Yilmaz B. , et al.
17. Serum caspase-cleaved cytokeratin-18 levels and outcomes after aneurysmal subarachnoid hemorrhage
- Yuan Z.G. , et al.
18. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma
- Sadeghi M. , et al.
19. Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: A pilot study
- Lorente L. , et al.
20. Significance of serum cytokeratin-18 in prediction of hepatocellular carcinoma in chronic hepatitis C infected egyptian patients
- El-Zefzafy W. , et al.
21. Clinical values of elevated serum cytokeratin-18 levels in hepatitis: A meta-analysis
- Yang Z.H. , et al.
22. Liver cell injury caused by bad habits
- Wang C.R. , et al.